SFMBT2 and medical procedure: In 2011 Zheng demonstrated that the miR-466 group is contained in the intron of Sfmbt2 (Zheng et al., 2011), while in 2012 Hunsberger et al. showed an increase in miR-466f expression in a rat model of middle cerebral artery occlusion (Hunsberger et al., 2012).